{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:22:38Z","timestamp":1768422158132,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19590259"],"award-info":[{"award-number":["19590259"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20013041"],"award-info":[{"award-number":["20013041"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.leukres.2025.108146","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:08:15Z","timestamp":1764868095000},"page":"108146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification and characterization of peptidyl-prolyl isomerase Pin1 as a new regulatory component of BCR::ABL1 degradation"],"prefix":"10.1016","volume":"160","author":[{"given":"Fujiko","family":"Tsukahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1606-578X","authenticated-orcid":false,"given":"Kenjiro","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Maru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2025.108146_bib1","doi-asserted-by":"crossref","unstructured":"R. Ren, Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia, Nature reviews. Cancer 5(3) (2005) 172\u2013183.","DOI":"10.1038\/nrc1567"},{"key":"10.1016\/j.leukres.2025.108146_bib2","doi-asserted-by":"crossref","unstructured":"Y. Maru, Molecular biology of chronic myeloid leukemia, Cancer science 103(9) (2012) 1601\u20131610.","DOI":"10.1111\/j.1349-7006.2012.02346.x"},{"key":"10.1016\/j.leukres.2025.108146_bib3","doi-asserted-by":"crossref","unstructured":"D.J. Barnes, D. Palaiologou, E. Panousopoulou, B. Schultheis, A.S. Yong, A. Wong, L. Pattacini, J.M. Goldman, J.V. Melo, Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia, Cancer research 65(19) (2005) 8912\u20138919.","DOI":"10.1158\/0008-5472.CAN-05-0076"},{"key":"10.1016\/j.leukres.2025.108146_bib4","doi-asserted-by":"crossref","unstructured":"R. Alves, A.C. Goncalves, S. Rutella, A.M. Almeida, J. De Las Rivas, I.P. Trougakos, A.B. Sarmento Ribeiro, Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance, Cancers 13(19) (2021).","DOI":"10.3390\/cancers13194820"},{"key":"10.1016\/j.leukres.2025.108146_bib5","doi-asserted-by":"crossref","unstructured":"J. Sun, R. Hu, M. Han, Y. Tan, M. Xie, S. Gao, J.F. Hu, Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia, International journal of biological sciences 20(1) (2024) 175\u2013181.","DOI":"10.7150\/ijbs.86305"},{"key":"10.1016\/j.leukres.2025.108146_bib6","doi-asserted-by":"crossref","unstructured":"F. Tsukahara, Y. Maru, Bag1 directly routes immature BCR-ABL for proteasomal degradation, Blood 116(18) (2010) 3582\u20133592.","DOI":"10.1182\/blood-2009-10-249623"},{"key":"10.1016\/j.leukres.2025.108146_bib7","doi-asserted-by":"crossref","unstructured":"M. Taipale, I. Krykbaeva, M. Koeva, C. Kayatekin, K.D. Westover, G.I. Karras, S. Lindquist, Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition, Cell 150(5) (2012) 987\u20131001.","DOI":"10.1016\/j.cell.2012.06.047"},{"key":"10.1016\/j.leukres.2025.108146_bib8","doi-asserted-by":"crossref","unstructured":"R.K. Kancha, N. Bartosch, J. Duyster, Analysis of conformational determinants underlying HSP90-kinase interaction, PloS one 8(7) (2013) e68394.","DOI":"10.1371\/journal.pone.0068394"},{"key":"10.1016\/j.leukres.2025.108146_bib9","doi-asserted-by":"crossref","unstructured":"A.S. Corbin, A. Agarwal, M. Loriaux, J. Cortes, M.W. Deininger, B.J. Druker, Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity, J Clin Invest 121(1) (2011) 396\u2013409.","DOI":"10.1172\/JCI35721"},{"key":"10.1016\/j.leukres.2025.108146_bib10","doi-asserted-by":"crossref","unstructured":"A. Hamilton, G.V. Helgason, M. Schemionek, B. Zhang, S. Myssina, E.K. Allan, F.E. Nicolini, C. Muller-Tidow, R. Bhatia, V.G. Brunton, S. Koschmieder, T.L. Holyoake, Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival, Blood 119(6) (2012) 1501\u20131510.","DOI":"10.1182\/blood-2010-12-326843"},{"key":"10.1016\/j.leukres.2025.108146_bib11","doi-asserted-by":"crossref","unstructured":"K.P. Lu, G. Finn, T.H. Lee, L.K. Nicholson, Prolyl cis-trans isomerization as a molecular timer, Nature chemical biology 3(10) (2007) 619\u2013629.","DOI":"10.1038\/nchembio.2007.35"},{"key":"10.1016\/j.leukres.2025.108146_bib12","doi-asserted-by":"crossref","unstructured":"D. Siepe, S. Jentsch, Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation, Nature cell biology 11(8) (2009) 967\u2013979.","DOI":"10.1038\/ncb1908"},{"key":"10.1016\/j.leukres.2025.108146_bib13","doi-asserted-by":"crossref","unstructured":"C. Schiene-Fischer, Multidomain peptidyl prolyl cis\/trans isomerases, Biochimica et Biophysica Acta 1850 (2016) 2005\u20132016.","DOI":"10.1016\/j.bbagen.2014.11.012"},{"key":"10.1016\/j.leukres.2025.108146_bib14","doi-asserted-by":"crossref","unstructured":"Z. Lu, T. Hunter, Prolyl isomerase Pin1 in cancer, Cell research 24(9) (2014) 1033\u20131049.","DOI":"10.1038\/cr.2014.109"},{"key":"10.1016\/j.leukres.2025.108146_bib15","doi-asserted-by":"crossref","unstructured":"K.P. Lu, X.Z. Zhou, The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease, Nature reviews. Molecular cell biology 8(11) (2007) 904\u2013916.","DOI":"10.1038\/nrm2261"},{"key":"10.1016\/j.leukres.2025.108146_bib16","doi-asserted-by":"crossref","unstructured":"P. Neviani, R. Santhanam, R. Trotta, M. Notari, B.W. Blaser, S. Liu, H. Mao, J.S. Chang, A. Galietta, A. Uttam, D.C. Roy, M. Valtieri, R. Bruner-Klisovic, M.A. Caligiuri, C.D. Bloomfield, G. Marcucci, D. Perrotti, The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein, Cancer cell 8(5) (2005) 355\u2013368.","DOI":"10.1016\/j.ccr.2005.10.015"},{"key":"10.1016\/j.leukres.2025.108146_bib17","doi-asserted-by":"crossref","unstructured":"W.B. Cao, J.F. Yao, S.Z. Feng, Y. He, E.L. Jiang, R.L. Zhang, D.L. Yang, M. Gong, X.H. Zheng, S.L. Chen, J.L. Sun, L.K. Zhou, M.Z. Han, BCR-ABL enhances the prolyl isomerase activity of Pin 1 by interacting with DAPK1 in ph(+) ALL, Cancer Med 7(6) (2018) 2530\u20132540.","DOI":"10.1002\/cam4.1478"},{"key":"10.1016\/j.leukres.2025.108146_bib18","doi-asserted-by":"crossref","unstructured":"P. Filippakopoulos, M. Kofler, O. Hantschel, G.D. Gish, F. Grebien, E. Salah, P. Neudecker, L.E. Kay, B.E. Turk, G. Superti-Furga, T. Pawson, S. Knapp, Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation, Cell 134(5) (2008) 793\u2013803.","DOI":"10.1016\/j.cell.2008.07.047"},{"key":"10.1016\/j.leukres.2025.108146_bib19","doi-asserted-by":"crossref","unstructured":"F. Grebien, O. Hantschel, J. Wojcik, I. Kaupe, B. Kovacic, A.M. Wyrzucki, G.D. Gish, S. Cerny-Reiterer, A. Koide, H. Beug, T. Pawson, P. Valent, S. Koide, G. Superti-Furga, Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis, Cell 147(2) (2011) 306\u2013319.","DOI":"10.1016\/j.cell.2011.08.046"},{"key":"10.1016\/j.leukres.2025.108146_bib20","doi-asserted-by":"crossref","unstructured":"H. Konig, M. Copland, S. Chu, R. Jove, T.L. Holyoake, R. Bhatia, Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells, Cancer research 68(23) (2008) 9624\u20139633.","DOI":"10.1158\/0008-5472.CAN-08-1131"},{"key":"10.1016\/j.leukres.2025.108146_bib21","doi-asserted-by":"crossref","unstructured":"D.W. Woessner, A.M. Eiring, B.J. Bruno, M.S. Zabriskie, K.R. Reynolds, G.D. Miller, T. O'Hare, M.W. Deininger, C.S. Lim, A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia, Leukemia 29(8) (2015) 1668\u20131675.","DOI":"10.1038\/leu.2015.53"},{"key":"10.1016\/j.leukres.2025.108146_bib22","doi-asserted-by":"crossref","unstructured":"J. Wojcik, A.J. Lamontanara, G. Grabe, A. Koide, L. Akin, B. Gerig, O. Hantschel, S. Koide, Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface, The Journal of biological chemistry 291(16) (2016) 8836\u20138847.","DOI":"10.1074\/jbc.M115.707901"},{"key":"10.1016\/j.leukres.2025.108146_bib23","doi-asserted-by":"crossref","unstructured":"Ashton C. Lai, Momar Toure, Doris Hellerschmieda, Jemilat Salamia, Saul Jaime-Figueroaa, Eunhwa Koa, John Hinesa, C.M. Crewsa, Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL, Angew Chem Int Ed Engl. 55(2) (2016) 807\u2013810.","DOI":"10.1002\/anie.201507634"},{"key":"10.1016\/j.leukres.2025.108146_bib24","doi-asserted-by":"crossref","unstructured":"X. Li, W. Li, Y. Zhang, L. Xu, Y. Song, Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia, Genes & Diseases 11(5) (2023) 101150.","DOI":"10.1016\/j.gendis.2023.101150"},{"key":"10.1016\/j.leukres.2025.108146_bib25","doi-asserted-by":"crossref","unstructured":"X.Z. Zhou, K.P. Lu, The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target, Nature reviews. Cancer 16(7) (2016) 463\u2013478.","DOI":"10.1038\/nrc.2016.49"},{"key":"10.1016\/j.leukres.2025.108146_bib26","doi-asserted-by":"crossref","unstructured":"C. Liu, L. Dan, Q. Li, O. Bajinka, X. Yuan, The mechanisms of Pin1 as targets for cancer therapy, Frontiers in immunology 15 (2024) 1482088.","DOI":"10.3389\/fimmu.2024.1482088"},{"key":"10.1016\/j.leukres.2025.108146_bib27","doi-asserted-by":"crossref","unstructured":"L.J. Blair, J.D. Baker, J.J. Sabbagh, C.A. Dickey, The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease, Journal of neurochemistry 133(1) (2015) 1\u201313.","DOI":"10.1111\/jnc.13033"},{"key":"10.1016\/j.leukres.2025.108146_bib28","doi-asserted-by":"crossref","unstructured":"A.G. Erlejman, S.A. De Leo, G.I. Mazaira, A.M. Molinari, M.F. Camisay, V. Fontana, M.B. Cox, G. Piwien-Pilipuk, M.D. Galigniana, NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity, The Journal of biological chemistry 289(38) (2014) 26263\u201326276.","DOI":"10.1074\/jbc.M114.582882"},{"key":"10.1016\/j.leukres.2025.108146_bib29","doi-asserted-by":"crossref","unstructured":"R. La Montagna, I. Caligiuri, A. Giordano, F. Rizzolio, Pin1 and nuclear receptors: a new language?, Journal of cellular physiology 228(9) (2013) 1799\u20131801.","DOI":"10.1002\/jcp.24316"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:02:14Z","timestamp":1768392134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625006368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"alternative-id":["S0145212625006368"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108146","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and characterization of peptidyl-prolyl isomerase Pin1 as a new regulatory component of BCR::ABL1 degradation","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108146"}}